Skip to menu Skip to content Skip to footer

2006

Journal Article

A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug

Mayer, Astrid, Francis, Roslyn J., Sharma, Surinder K., Tolner, Berend, Springer, Caroline J., Martin, Jan, Boxer, Geoff M., Bell, James, Green, Alan J., Hartley, John A., Cruickshank, Clare, Wren, Julie, Chester, Kerry A. and Begent, Richard H. J. (2006). A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. Clinical Cancer Research, 12 (21), 6509-6516. doi: 10.1158/1078-0432.CCR-06-0769

A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug